User profiles for Piedad Ussetti

Maria Piedad Ussetti Gil

Hospital Universitario Puerta de Hierro
Verified email at separ.es
Cited by 3541

Results of clinical lung transplant from uncontrolled non-heart-beating donors

…, P Gámez, M Córdoba, J Moradiellos, P Ussetti… - The Journal of heart and …, 2007 - Elsevier
BACKGROUND: The scarcity of grafts for lung transplant and the growing number of
candidates expecting an organ has led to an increase of deaths in patients waiting for lung …

Monitoring breathing rate at home allows early identification of COPD exacerbations

…, M Calle-Rubio, RM de Molina, MV Falcones, P Ussetti… - Chest, 2012 - Elsevier
Background Respiratory frequency increases during exacerbations of COPD (ECOPD). We
hypothesized that this increase can be detected at home before ECOPD hospitalization. …

Clinical lung transplantation from uncontrolled non–heart-beating donors revisited

…, J Moradiellos, JM Naranjo, P Ussetti… - The Journal of heart and …, 2012 - Elsevier
BACKGROUND: The aim of our study is to review and update the long-term results from our
previously published series of lung transplantation in uncontrolled non–heart-beating …

Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas

…, GF Sanz, F Torrico, DT Tendero, P Ussetti… - Transplantation …, 2011 - Elsevier
The substantial immigration into Spain from endemic areas of Chagas disease such as Latin
America has increased the number of potential donors of organs and tissues. In addition, …

Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety

V Monforte, P Ussetti, R López, J Gavaldà… - The Journal of heart and …, 2009 - Elsevier
BACKGROUND: The main problem with using nebulized liposomal amphotericin (n-LAB) as
prophylaxis for Aspergillus infection after lung transplantation is the lack of knowledge of its …

Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation

V Monforte, P Ussetti, J Gavaldà, C Bravo… - The Journal of heart and …, 2010 - Elsevier
BACKGROUND: Nebulized amphotericin B deoxycholate (n-ABD) is used to prevent
Aspergillus infection in lung transplantation. Nebulized liposomal amphotericin B (n-LAB) is …

New concepts and best practices for management of pre-and post-transplantation cancer

…, A Rimola, A Román, D Serón, P Ussetti - Transplantation …, 2012 - Elsevier
Solid-organ transplant recipients are at increased risk of developing cancer compared with
the general population. Tumours can arise de novo, as a recurrence of a preexisting …

The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients

…, LA Pulpón, A Rimola, D Serón, P Ussetti - Transplantation …, 2014 - Elsevier
Transplant recipients receiving immunosuppressive therapy are at increased risk of active
cytomegalovirus (CMV) infection and disease. Without appropriate prophylaxis, as many as 80…

10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation

…, C Berastegui, B Saez, J Riera, P Ussetti… - Transplant …, 2016 - Wiley Online Library
The aim of this study was to assess the outcome and tolerability of prophylactic nebulized
liposomal amphotericin B (n‐ LAB ) in lung transplant recipients ( LTR ) and the changing …

Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021

…, CLJ Teng, J Torre‐Cisneros, P Ussetti… - Transplant Infectious …, 2022 - Wiley Online Library
The CMV Symposium in September 2021 was an international conference dedicated to
cytomegalovirus (CMV) infection after solid organ or hematopoietic stem cell transplantation. …